Sumitomo Seika Chemicals Company, Limited.
4008・Prime Market・Chemicals
Business
Founded in 1944, Sumitomo Seika Chemicals is a specialty chemicals manufacturer with two core businesses: Superabsorbent Polymer (SAP) and Functional Materials. Superabsorbent Polymer is manufactured and sold for hygiene materials such as disposable diapers and sanitary products, as well as for industrial water-blocking materials, and is the company's mainstay business, accounting for approximately 78% of net sales. Functional Materials covers a wide variety of chemical products, including Water-Soluble Polymers, Emulsions & Fine Particle Polymers, Electronics Gas, PSA oxygen generators, and Pharmaceutical Products. In addition to its domestic plants in Himeji, Beppu, and Chiba, the company has manufacturing and sales sites in Singapore, Belgium, South Korea, China, and Taiwan, conducting global business operations centered on Asia. Its major customers span hygiene materials manufacturers, semiconductor and electronic component manufacturers, and medical institutions, among others.
Business Model
In the Superabsorbent Polymer business, the company manufactures differentiated products using its proprietary batch process based on inverse-phase suspension polymerization, and sells them directly to global hygiene materials manufacturers. In the Functional Materials business, it manufactures and sells a wide variety of chemical products, gas products, and PSA equipment, supplementing overall earnings. Raw fuel (naphtha) costs represent the primary variable cost, and profit margins are managed through price pass-through and unit cost improvements achieved via rationalization. The basic policy is a consolidated payout ratio of 30% or more, with a balanced allocation across capital expenditures, R&D, and shareholder returns.
Company Strengths
Sumitomo Seika possesses a proprietary inverse-phase suspension polymerization method (batch process) for manufacturing Superabsorbent Polymer, enabling functional customization tailored to regional and application-specific needs. In FY2023, the company launched a new product that reduces Superabsorbent Polymer usage by approximately 10%, and plans to launch a product achieving approximately 20% reduction in FY2026. This manufacturing advantage, which is difficult for competitors to replicate in a short period, forms the basis of product differentiation.
The company operates manufacturing facilities in Japan (Himeji, Beppu, Chiba), Singapore, Belgium, South Korea, and China, establishing a global supply system that meets demand in Asia. Its Singapore subsidiary continues to invest in expanding Superabsorbent Polymer manufacturing equipment, with construction in progress accumulating to ¥28,357 million. Capital expenditure for FY2026 (ending March 2026) totaled ¥12,210 million, of which ¥8,282 million was allocated to the Superabsorbent Polymer business.
As of the end of FY2026 (ending March 2026), the equity ratio stood at 67.8% and the D/E ratio at 0.17x, indicating high financial soundness. Interest-bearing debt remained limited to ¥17,934 million, while cash and cash equivalents totaled ¥17,989 million. Operating cash flow was robust at ¥17,480 million, maintaining a financial structure capable of funding capital expenditure, research and development, and shareholder returns through internal funds and borrowings.
ENVALITH's Perspective
Performance Trend
Revenue for FY2026 (ending March 2026) was ¥148,354 million (up 0.5% year on year), essentially flat, while operating profit rose sharply to ¥14,464 million (up 35.0% year on year) and ordinary profit rose to ¥15,249 million (up 37.3% year on year). As an external factor, the decline in naphtha prices from ¥75,600/KL to ¥65,200/KL directly contributed to improved manufacturing costs. In the SAP segment, operating profit increased 42.5% due to higher sales volume in markets such as China and lower raw material and fuel costs. On the other hand, net income was limited to ¥7,677 million (up 28.8% year on year) due to the recording of extraordinary losses, including ¥3,208 million in expenses related to overbilling and ¥1,241 million in impairment losses. Over the five-year trend, revenue expanded steadily from ¥115,583 million to ¥148,354 million, and operating profit grew from ¥8,072 million to ¥14,464 million. ROE improved from 6.3% to 7.8%.
Growth Strategy
Aiming for medium-term growth through three pillars: SAP capacity expansion, new product development, and restructuring of Functional Materials
Continuing investment to enhance SAP manufacturing facilities at the consolidated Singapore subsidiary. Construction in progress increased from ¥20,060 million at the end of FY2025 (ending March 2025) to ¥28,357 million at the end of FY2026 (ending March 2026), aiming to capture Asian demand through expanded production capacity once the facilities are completed. Expenditure for acquisition of property, plant and equipment was ¥12,387 million in FY2026 (ending March 2026).
Following the termination of the IR latex business, the company is compensating through expanded sales of Water-Soluble Polymers and PSA oxygen generators. Operating profit for Functional Materials in FY2026 (ending March 2026) was ¥2,910 million (up 11.0% year on year), on a recovery trend. The company continues to develop new products such as Electronics Gas and next-generation semiconductor materials, aiming to diversify revenue sources.
The company implemented a 5-for-1 stock split effective April 1, 2026, aiming to broaden its investor base. Annual dividend for FY2026 (ending March 2026) was ¥220 (pre-split), with a payout ratio of 37.3%. Furthermore, at the board of directors meeting on May 12, 2026, the company resolved to cancel 5,275,195 treasury shares (scheduled for May 26, 2026) and to conduct additional share repurchases of up to ¥1,000 million / 840,000 shares, promoting improved capital efficiency and enhanced shareholder returns.
Last updated: July 19, 2026